PROVENGE helps you fight prostate cancer using your own immune system

PROVENGE is the first approved immunotherapy for advanced prostate cancer. KCUC is now an exclusive provider.

Key Discussion Points

  • In a clinical study, PROVENGE helped men live longer. In this study, more men treated with PROVENGE were alive at 3 years than men who were not treated.
  • Most side effects are generally mild to moderate and last only a day or two. The most common side effects are chills, fatigue, fever, back pain, nausea, joint ache, and headache.
  • PROVENGE therapy can be completed in about a month with only 3 infusions.
American College of Radiology Radiation Oncology Accredited Facility
Accredited by the premier credentialing body for radiation oncology, ACR (The American College of Radiology).